Agreement signedPublished 18 Aug 2025

XRA 4 Corp. /
HilleVax

XRA 4 Corp. agrees to acquire HilleVax

Buy side: XRA 4 Corp.
Buy sideXRA 4 Corp.
Target: HilleVax
TargetHilleVax
XRA 4 Corp. · 18 Aug 2025Source
Buy side: XRA 4 Corp.
Buy sideXRA 4 Corp.
Target: HilleVax
TargetHilleVax
01 / BuyerXRA 4 Corp.
02 / TargetHilleVax
Source for the buyer and target: XRA 4 Corp.

For the buyer and target.

“Agreement and Plan of Merger, by and among XOMA Royalty Corporation, XRA 4 Corp. and HilleVax, Inc., dated August 4, 2025 (incorporated by reference to Exhibit 2.1 to HilleVax’s Current Report on Form 8-K filed with the SEC on August 4, 2025).”

Published 18 Aug 2025

Open the source
01

What happened

XRA 4 Corp. and HilleVax have entered into a merger agreement. The transaction includes an offer followed by a merger, subject to the agreement’s terms and conditions. [01]

The filing describes HilleVax’s norovirus vaccine programs. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · XRA 4 Corp.

XRA 4 Corp. agrees to acquire HilleVax

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by XRA 4 Corp.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.